# Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery

> **NCT01120405** · PHASE3 · COMPLETED · sponsor: **Air Liquide Santé International** · enrollment: 600 (actual)

## Conditions studied

- Elevated Cardiac Risk
- Coronary Arteries Disease Risk

## Interventions

- **DRUG:** Xenon
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT01120405
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2014-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120405, "Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01120405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*